Sweden's Ambea Q2 sales beat estimates on higher occupancy
Sweden's Ambea Q2 sales beat estimates on higher occupancy
Overview
Sweden care provider's Q2 net sales rose 7% yr/yr, beating analyst expectations
Adjusted EBITA and EPS improved on higher occupancy, operational gains, and Nordic expansion
Company announced recommended public offer to acquire Humana to boost Nordic presence
Outlook
Ambea did not provide specific financial guidance for the current qtr or full yr
Result Drivers
HIGHER OCCUPANCY - Co said increased occupancy rates in care units supported revenue and earnings growth
OPERATIONAL IMPROVEMENTS - Co cited operational improvements, particularly in Norway and Denmark, as contributing to stronger results
NORDIC EXPANSION - Co said ongoing expansion, including new care unit openings and acquisitions, drove growth
Company press release: ID:nWkr2j6Fl1
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Beat | SEK 4.39 bln | SEK 4.32 bln (3 Analysts) |
Q2 EPS |
| SEK 2.13 |
|
Q2 ADJ-EBITDA |
| SEK 397 mln |
|
Q2 EBIT |
| SEK 353 mln |
|
Q2 EBITA |
| SEK 378 mln |
|
Reuters Recommended Reads
Aug 17 - Mobile healthcare provider DocGo's Q2 revenue misses on wind-down of migrant programs
Aug 18 - Denmark's Coloplast Q3 revenue up on Chronic Care, Urology growth
Aug 18 - China's Ping An Healthcare H1 revenue profit jumps on corporate client base expansion
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ambea publ AB
See all newsBrief: Ambea: Final Outcome Of Recommended Public Offer To Shareholders Of Humana
Brief: Ambea, Age-Well Partner To Advance Innovation, Technology In Senior Care
Brief: Humana Applies For Delisting, Convenes Extraordinary General Meeting
Brief: Ambea Unit Nytida Buys Imera
Brief: Ambea Gets Necessary Regulatory Approvals For Humana Acquisition